Logo     Print Page  Close Window


SEC Filings


8-K
FIBROCELL SCIENCE, INC. filed this Form 8-K on 09/07/2004
Entire Document
 


SIGNATURE

        Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ISOLAGEN, INC.

Date: September 7, 2004

 

By:

/s/  
JEFFREY TOMZ      
Chief Financial Officer